Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Shoukat A, Moghadas SM, Agent-based modelling: an overview with application to infectious disease dynamics 2020, arXiv:2007.04192.
Shoukat A, Vilches T, Moghadas SM, Cost-effectiveness of prophylactic Zika virus vaccine in the Americas, Emerging Infectious Diseases 2019, 12: 2191–2196.
Champredon D, Zhang K, Smieja M, Moghadas SM, Clostridium difficile intervention timelines for diagnosis, isolation, and treatment, American Journal of Infection Control 2019, 47: 1370–1374.
Wang Z, Röst G, Moghadas SM, Delay in booster schedule as a control parameter in vaccination dynamics, Journal of Mathematical Biology 2019, 79: 2157–2182.
Champredon D, Moghadas SM, On the reproduction number of epidemics with sub-exponential growth, Trends in Biomathematics: Mathematical Modelling for Health, Harvesting, and Population Dynamics 2019, 309–320.
Vilches T, Jaberi-Douraki M, Moghadas SM, Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour, Epidemiology and Infection 2019, 147: e75, 1–8.
Abdollahi E, Shoukat A, Moghadas SM, Modelling therapeutic vaccines, Trends in Biomathematics: Modelling Cells, Flows, Epidemics, and the Environment, Springer 2019, 381–394.
Shoukat A, Vilches TN, Moghadas SM, Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia, BMC Medicine 2018, 16: 100.
Shoukat A, Van Exan RJ, Moghadas SM, Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype ‘a’, Vaccine 2018, 36: 1681–1688.
Röst G, Kuniya T, Moghadas SM, Wu J, Global dynamics of an epidemiological model with age-of-infection dependent treatment rate, Ricerche di Matematica 2018, 67: 125–140.